MK-777 (Acetamoren): uses, dosing & the facts

A next-generation oral growth hormone secretagogue optimized from MK-677. Features enhanced receptor selectivity and pharmacokinetics with 92% greater affinity to GHS-R1a receptor. This is an evidence-graded reference — what it is, what it's used for, typical reported dosing, half-life, side effects, and how to track it. It is educational, not medical advice or a recommendation to use a research compound.

By OptiPin Editorial·Last updated July 2026

Status

Research use only · not FDA-approved. Reported dosing below reflects community-discussed patterns, presented for information only — not a dose recommendation. For the US regulatory picture on research peptides, see the 2026 FDA compounding status.

Class

Oral GH secretagogue

Used for

Enhanced muscle growth without hunger stimulation

Half-life

Approximately 8-10 h…

Status

Research use only

TL;DR

• MK-777 (Acetamoren) — Oral GH secretagogue. A next-generation oral growth hormone secretagogue optimized from MK-677.
• Commonly used for enhanced muscle growth without hunger stimulation, improved sleep architecture (deeper rem), bone density enhancement.
• Half-life: Approximately 8-10 hours.
• Status: Research use only · not FDA-approved — an educational reference, not a dose protocol or sourcing advice.

What MK-777 (Acetamoren) is

A next-generation oral growth hormone secretagogue optimized from MK-677. Features enhanced receptor selectivity and pharmacokinetics with 92% greater affinity to GHS-R1a receptor.

What MK-777 (Acetamoren) is used for

• Enhanced muscle growth without hunger stimulation
• Improved sleep architecture (deeper REM)
• Bone density enhancement
• Tissue-selective IGF-1 activation (muscle over visceral fat)
• Growth hormone stimulation without injections
• Convenience of oral administration with superior profile

These are reported/community uses, not proven clinical outcomes. Most research peptides have limited human trial data behind such claims.

Typical reported dosing

Oral	10-30mg per day, taken orally once daily, typically before bed

Presented as commonly-reported patterns for information only — not a dose recommendation. MK-777 (Acetamoren) dosing is a decision for a qualified clinician.

Half-life & cycling

Half-life: Approximately 8-10 hours. Half-life drives dosing frequency and how quickly the compound clears — see it plotted on the half-life visualizer.

Cycling

Can be used for extended periods. Typical cycles: 6-12 months. Some use continuously.

Side effects & warnings

• Reduced appetite stimulation compared to MK-677
• Minimal lethargy
• No cortisol level disruption
• No glucose homeostasis disruption
• Generally well-tolerated

68% less hunger stimulation than MK-677. No cortisol or glucose disruption. Superior to MK-677 with longer half-life (8-10 hours vs 4-6 hours). Enhanced receptor affinity. Not a true peptide.

Not a prescription, a dose, or a sourcing guide. MK-777 (Acetamoren) is a research compound; safety and efficacy in humans are not fully established, and research-grade material has no guarantee of purity, sterility, or stated strength. OptiPin is a tracking tool and does not recommend using research chemicals. Discuss any peptide with a qualified clinician.

Tracking MK-777 (Acetamoren) in OptiPin

If you're tracking a MK-777 (Acetamoren) protocol, OptiPin logs each dose with reminders and site rotation, charts the outcome you care about over your dose timeline, keeps per-vial inventory with runout warnings, and (where relevant) does the reconstitution math — all on-device, no account.

Track it properly

Log doses, outcomes & vials in OptiPin

Reminders, outcome-over-dose charts, vial runout warnings, and built-in reconstitution math — all on-device.

Download on the App Store

FAQ

What is MK-777 (Acetamoren)?

A next-generation oral growth hormone secretagogue optimized from MK-677. Features enhanced receptor selectivity and pharmacokinetics with 92% greater affinity to GHS-R1a receptor.

What is MK-777 (Acetamoren) used for?

Commonly discussed uses include: enhanced muscle growth without hunger stimulation, improved sleep architecture (deeper rem), bone density enhancement, tissue-selective igf-1 activation (muscle over visceral fat), growth hormone stimulation without injections, convenience of oral administration with superior profile. These are reported uses, not proven outcomes or a recommendation.

How is MK-777 (Acetamoren) dosed?

Commonly reported dosing: Oral — 10-30mg per day, taken orally once daily, typically before bed. This reflects patterns discussed in the community and is presented for information only, not as a dose recommendation — MK-777 (Acetamoren) is not an approved medicine and dosing should involve a qualified clinician.

What is MK-777 (Acetamoren)'s half-life?

Approximately 8-10 hours. Half-life shapes how often it is dosed and how quickly it clears.

What are MK-777 (Acetamoren)'s side effects?

Reported effects include: reduced appetite stimulation compared to mk-677, minimal lethargy, no cortisol level disruption, no glucose homeostasis disruption, generally well-tolerated. Because it is a research compound, its safety profile is not fully characterized; discuss risks with a clinician.

Educational only, not medical advice. MK-777 (Acetamoren) is a research compound and is not an approved medicine for the uses described. OptiPin is a tracking tool and does not provide dosing or treatment advice. Discuss any peptide with a qualified clinician.

Evidence & further reading

Search the peer-reviewed literature for MK-777 (Acetamoren) on PubMed (entry point to the primary evidence base, not a specific citation).
MK-777 (Acetamoren) on ClinicalTrials.gov — registered human trials, if any.
US FDA / 503A compounding status of research peptides (2026).
OptiPin peptides guide — categories, evidence grading, and how to run a protocol honestly.

Sermorelin · HGH (Somatropin) · Thymosin Alpha-1 · Wolverine · BPC-157 · TB-500 · Reconstitution calculator · All peptides